Stockreport

MediciNova launches Phase 2/3 study of MN-166 in degenerative spinal cord condition; shares up 2% [Seeking Alpha]

MediciNova, Inc.  (MNOV) 
Last medicinova, inc. earnings: 4/23 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: medicinova.com/investor-relations/media-archive
PDF MediciNova launches Phase 2/3 study of MN-166 in degenerative spinal cord condition; shares up 2% [Read more]